Indna Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.16 Cr
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.15 Cr
- Satisfied Charges ₹ 6.00 M
- Revenue Growth 612.77%
- Profit Growth 581.49%
- Ebitda 12283.59%
- Net Worth 48.85%
- Total Assets 68.89%
About Indna Lifesciences
Indna Lifesciences Private Limited (ILPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 May 2012 and has a history of 12 years and nine months. Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.16 Cr.
The company currently has active open charges totaling ₹2.15 Cr. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sujata Kar, Birendra Banerjee, and Paromita Chattoraj serve as directors at the Company.
Company Details
- Location
Khorda, Odisha, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85195OR2012PTC015374
- Company No.
015374
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2012
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Indna Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Birendra Banerjee  | Managing Director | 11-May-2012 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paromita Chattoraj | Director | 11-May-2012 | Current |
| Sujata Kar | Director | 28-Feb-2019 | Current |
Financial Performance of Indna Lifesciences.
Indna Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 612.77% increase. The company also saw a substantial improvement in profitability, with a 581.49% increase in profit. The company's net worth Soared by an impressive increase of 48.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indna Lifesciences?
In 2021, Indna Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kar Clinic & Hospital Private LimitedSujata Kar is a mutual person
Pranvayu Seva Private LimitedBirendra Banerjee and Paromita Chattoraj are mutual person
- Eva Biologics Private Limited
Birendra Banerjee and Paromita Chattoraj are mutual person
Charges (Loans)
₹2.15 Cr
₹0.60 Cr
Charges Breakdown by Lending Institutions
- Others : 2.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2020 | Others | ₹2.15 Cr | Open |
| 20 Dec 2018 | State Bank Of India | ₹6.00 M | Satisfied |
How Many Employees Work at Indna Lifesciences?
Unlock and access historical data on people associated with Indna Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indna Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indna Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
